PMVP
Pmv Pharmaceuticals, Inc.
$1.43-0.01 (-0.69%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
PMV Pharmaceuticals, Inc. (PMVP) is a publicly traded company with 4 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 19 transactions (past 365 days)
| 2026-03-09 | 2026-03-05 | Carulli Michael | CFO | Award | 240,000 | $1.53 | $367,200 |
| 2026-03-09 | 2026-03-05 | Ticktin Robert | COO | Award | 319,270 | $1.53 | $488,483 |
| 2026-03-09 | 2026-03-05 | Jalota Deepika | CDO | Award | 303,310 | $1.53 | $464,064 |
| 2026-03-09 | 2026-03-05 | Mack David Henry | CEO | Award | 744,960 | $1.53 | $1,139,789 |
| 2025-10-29 | 2025-10-27 | Mack David Henry | CEO | Exercise Conversion | 220,643 | $0.00 | $0 |
| 2025-10-29 | 2025-10-27 | Mack David Henry | CEO | Exercise Conversion | 220,643 | $1.37 | $302,281 |
| 2025-10-27 | 2025-10-23 | Orbimed Advisors Llc | 10% Owner | Sale | 1,000,000 | $1.52 | -$1,520,000 |
| 2025-09-12 | 2025-09-10 | Orbimed Advisors Llc | 10% Owner | Sale | 500,000 | $1.80 | -$900,000 |
| 2025-07-03 | 2025-07-01 | Carulli Michael | CFO | Sale | 28,249 | $1.07 | -$30,085 |
| 2025-07-03 | 2025-07-01 | Mack David Henry | CEO | Sale | 58,411 | $1.07 | -$62,208 |
PMVP
CEO
Exercise Conversion
$302.3K
Mack David Henry220,643 shares @ $1.37
Filed 2025-10-29Trade 2025-10-27
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.